Penn Medicine

Penn Medicine is a healthcare institution where dedicated professionals work tirelessly to make breakthroughs, heal hearts, deliver hopeful news, and provide comfort and reassurance to patients. Physicians, scientists, nurses, technicians, and social workers at Penn Medicine strive to unlock medical science that can offer the gift of more time and positively impact human lives. Their collective efforts focus on advancing healthcare and changing the course of patient care through innovative research and compassionate medical services.

Kevin B. Mahoney

CEO

11 past transactions

Doylestown Hospital

Acquisition in 2024
Doylestown Hospital is a Bucks County-based community hospital that offers a range of healthcare services.

HealthShare Exchange

Grant in 2023
HealthShare Exchange is a healthcare data collector that offers health information exchange and population health monitor services.

TwentyEight

Seed Round in 2023
TwentyEight Health, Inc. is a Brooklyn-based company founded in 2018 that focuses on providing a digital healthcare platform for women's reproductive and sexual health. The platform offers online doctor evaluations for birth control prescriptions, quick home deliveries of medications, and secure messaging with healthcare professionals. By prioritizing accessibility, TwentyEight Health aims to serve underserved women, particularly Medicaid recipients, and to revolutionize the way they access inclusive and high-quality health services. The company's innovative approach to telemedicine and care coordination facilitates a more convenient and affordable means for women to manage their health needs.

Interius BioTherapeutics

Series A in 2021
Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas. Intravenous in vivo CAR treatment, which treats B cell lymphomas, is the company's flagship program. Its unique engineering provides exceptional target tissue specificity. The business is working on a second initiative to address autoimmune conditions. With the help of Interius, a novel and distinct therapeutic modality for the precise administration of gene therapies may soon be made available to patients in expanded care settings, without the need for preconditioning chemotherapy.

Carisma Therapeutics

Series B in 2021
Carisma Therapeutics is a clinical-stage biotechnology company dedicated to developing innovative immunotherapies for cancer and other serious diseases through its proprietary chimeric antigen receptor macrophage technology. The company focuses on engineering macrophages and monocytes, which are specialized white blood cells, to enhance their ability to infiltrate solid tumors and deliver potent cellular immunotherapy. By leveraging advanced cell engineering techniques, Carisma aims to provide effective treatments that enable patients with solid tumors to benefit from targeted and robust cancer therapies.

Carisma Therapeutics

Series A in 2018
Carisma Therapeutics is a clinical-stage biotechnology company dedicated to developing innovative immunotherapies for cancer and other serious diseases through its proprietary chimeric antigen receptor macrophage technology. The company focuses on engineering macrophages and monocytes, which are specialized white blood cells, to enhance their ability to infiltrate solid tumors and deliver potent cellular immunotherapy. By leveraging advanced cell engineering techniques, Carisma aims to provide effective treatments that enable patients with solid tumors to benefit from targeted and robust cancer therapies.

Tissue Analytics

Series A in 2018
Tissue Analytics, Inc. is a Baltimore-based company that specializes in developing a mobile application aimed at improving the management of chronic wounds, burns, and skin conditions. Founded in 2014, the company provides a solution for home health agencies, nursing homes, and medical practices to capture patient photographs and perform wound analysis. The platform automatically generates formatted patient reports and enables tracking of treatment progress. It also includes remote evaluation tools and employs advanced algorithms for skin and wound analysis, ensuring secure transmission of protected health information from patients to healthcare providers. Tissue Analytics operates as a subsidiary of Net Health Systems, Inc. and has formed a strategic alliance with MolecuLight Inc.

Keriton

Seed Round in 2017
Keriton LLC is a company that specializes in providing a pumped breast milk management system tailored for neonatal intensive care units (NICUs). Its platform facilitates the tracking of milk-bottle inventory, feeding orders, and recipes through mobile devices. The system enhances patient safety by implementing first-in-first-out (FIFO) bottle flow management, notifying users of expiry dates, and issuing alerts for potential misfeeds. Additionally, Keriton offers a media-sharing platform that allows nurses to share photos and videos of NICU babies with their mothers, fostering communication and engagement. The company also provides real-time insights into the milk production patterns of lactating mothers. Incorporated in 2016 and based in Philadelphia, Pennsylvania, Keriton's software-as-a-service (SaaS) solution has been deployed in various large healthcare systems, managing over 1.5 million feeds and significantly reducing nursing errors while improving overall patient outcomes.

Grand Round Table

Seed Round in 2015
Grand Round Table Inc. is a company based in Philadelphia, Pennsylvania, that specializes in developing clinical decision support tools for healthcare providers. Its flagship product, Grand Round Table, is an integrated system designed to enhance the diagnostic capabilities of doctors by leveraging a vast database of deidentified health records, case reports, and evidence-based medical literature. This technology extracts pertinent information from patients' charts and matches it with similar cases, allowing physicians to reference previous treatments and outcomes in comparable scenarios. By facilitating faster and more accurate treatment plans, Grand Round Table aims to improve patient care, reduce unnecessary medical tests and consultations, and ultimately contribute to cost savings for hospitals and clinics. Established in 2011, the company focuses on translating available medical knowledge into actionable insights to support healthcare professionals in making informed decisions for diagnostically challenging cases.

Tissue Analytics

Pre Seed Round in 2014
Tissue Analytics, Inc. is a Baltimore-based company that specializes in developing a mobile application aimed at improving the management of chronic wounds, burns, and skin conditions. Founded in 2014, the company provides a solution for home health agencies, nursing homes, and medical practices to capture patient photographs and perform wound analysis. The platform automatically generates formatted patient reports and enables tracking of treatment progress. It also includes remote evaluation tools and employs advanced algorithms for skin and wound analysis, ensuring secure transmission of protected health information from patients to healthcare providers. Tissue Analytics operates as a subsidiary of Net Health Systems, Inc. and has formed a strategic alliance with MolecuLight Inc.

Fitly

Seed Round in 2013
Fitly, Inc. specializes in developing innovative solutions that promote healthy eating among families and children. The company offers the SmartPlate App, which employs food recognition technology to assist users in planning, purchasing, and preparing nutritious meals. This app allows individuals to choose from various goal-specific programs or create custom plans, while pairing with a countertop device that accurately analyzes and tracks the nutritional content of meals. Fitly's SmartPlate TopView device provides personalized guidance on healthy eating habits by analyzing entire meals and offering insights into macro and micronutrient intake. The company's solutions focus on various aspects of wellness, including weight management, portion control, and dietary needs, aiming to enhance human health without the need for restrictive diets. Established in 2011, Fitly is headquartered in Philadelphia, Pennsylvania.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.